Trajectories of CD4<sup>+</sup>/CD8<sup>+</sup> T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study

Trajectories of CD4<sup>+</sup>/CD8<sup>+</sup> T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study

The aim of the present study was to evaluate CD4/CD8 dynamics in patients on dolutegravir (DTG)-based two-drug regimens (2DRs) and compare them with DTG-containing triple-drug regimens (3DRs). A prospective observational study was performed in the context of the SCOLTA cohort. Experienced PWH with H...

Full description

Bibliographic Details
Main Authors: Lucia Taramasso, Antonio Falletta, Elena Ricci, Giancarlo Orofino, Nicola Squillace, Barbara Menzaghi, Giuseppe Vittorio De Socio, Chiara Molteni, Giovanni Francesco Pellicanò, Roberto Gulminetti, Giordano Madeddu, Eleonora Sarchi, Francesca Vichi, Benedetto Maurizio Celesia, Paolo Bonfanti, Antonio Di Biagio
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Viruses
Subjects:
dolutegravir
two-drug regimen
three-drug regimen
ART
immune recovery
CD4/CD8 ratio
Online Access:https://www.mdpi.com/1999-4915/14/11/2315

Internet

https://www.mdpi.com/1999-4915/14/11/2315

Similar Items